Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: Implications for Prostate Safety.
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2013
At a glance
- Drugs Dutasteride (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 01 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 02 Oct 2008 New trial record.